BiotechTube
Home/i-Cordis/Bradley Keller, PhD
BK

Bradley Keller, PhD

VP Preclinical Development

i-Cordis

Therapeutic Areas

Cardiovascular

i-Cordis Pipeline

DrugIndicationPhase
PEGylated PirfenidoneHeart Failure with Preserved Ejection Fraction (HFpEF)Pre-clinical

Leadership Team at i-Cordis

DM
Douglas Mann, MD
Founder
LA
Luigi Adamo, MD, PhD
Founder
JR
Jennifer Riggs, PhD
Head of Medicinal Chemistry
JB
Jennifer Baltz, PhD
Chief Operating Officer
View full i-Cordis profile